The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia.
Appelbaum, F R
The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia. [electronic resource] - Transplantation Nov 1992 - 829-33 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0041-1337
10.1097/00007890-199211000-00012 doi
Adolescent
Adult
Antibodies
Antigens, CD--immunology
Antigens, Differentiation, Myelomonocytic--immunology
Bone Marrow--radiation effects
Bone Marrow Transplantation
Female
Half-Life
Humans
Iodine Radioisotopes
Leukemia, Myeloid, Acute--surgery
Male
Middle Aged
Pharmacokinetics
Sialic Acid Binding Ig-like Lectin 3
Time Factors
The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia. [electronic resource] - Transplantation Nov 1992 - 829-33 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0041-1337
10.1097/00007890-199211000-00012 doi
Adolescent
Adult
Antibodies
Antigens, CD--immunology
Antigens, Differentiation, Myelomonocytic--immunology
Bone Marrow--radiation effects
Bone Marrow Transplantation
Female
Half-Life
Humans
Iodine Radioisotopes
Leukemia, Myeloid, Acute--surgery
Male
Middle Aged
Pharmacokinetics
Sialic Acid Binding Ig-like Lectin 3
Time Factors